Xtx Topco LTD Fulcrum Therapeutics, Inc. Transaction History

Xtx Topco LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$6.7 - $12.0 $88,131 - $157,848	13,154 New	13,154 $124,000
Q3 2023 Nov 13, 2023	SELL	$3.25 - $6.08 $143,806 - $269,027	-44,248 Reduced 53.2%	38,918 $172,000
Q2 2023 Aug 14, 2023	SELL	$2.26 - $3.8 $91,760 - $154,287	-40,602 Reduced 32.8%	83,166 $274,000
Q1 2023 May 12, 2023	BUY	$2.83 - $13.99 $251,547 - $1.24 Million	88,886 Added 254.82%	123,768 $352,000
Q4 2022 Feb 14, 2023	BUY	$5.01 - $8.35 $174,758 - $291,264	34,882 New	34,882 $253,000
Q2 2022 Aug 15, 2022	BUY	$4.2 - $24.0 $116,755 - $667,176	27,799 New	27,799 $136,000

150

52.2M

6.91M

1.9M

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $237M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.